Abstract: Disclosed are novel method of inducing tissue regeneration through administration of gamma delta T cells that have been endowed regenerative activity. In one embodiment said regenerative active is bestowed upon said cells by culture with a regenerative cell population. In other embodiments a chimeric antigen receptor (CAR) is transfected which induces generation of regenerative substances upon activation of said CAR. Regenerative factors useful for the treatment of the invention depend on the condition for which treatment is desired, for example, in neurological conditions production of brain derived neurotrophic factor is produced upon activation of said CAR, wherein said CAR recognizes antigens or neoantigens associated with neuronal injury.

Abstract: A method of creating antigen-specific, chimeric antigen receptor (CAR) T cells capable of secreting regenerative growth factors upon activation of said CAR. In one embodiment said regenerative CAR-T cells possess a CAR capable of selectively recognizing damaged tissue. In one embodiment said CAR recognizes damage-associated molecular patterns (DAMPs) such as ATP, HMGB-1, matricryptins, cold-inducible RNA-binding protein, histones and mitochondrial DNA. Upon activation of said CAR said regenerative CAR-T cell is induced to produce one or more regenerative growth factors. In some embodiments the invention provides a suicide gene in said regenerative CAR-T cells in order to remove said cells after their therapeutic purpose is completed.

Abstract: Conventional customer relationship management (CRM) systems provide limited data that are not conducive to the calculation of the qualified portion of a sales pipeline. Accordingly, embodiments calculate a metric of qualified pipeline from this limited data, and can do so across one or a plurality of various dimensions. In addition, embodiments can forecast the metric of qualified pipeline at a future time and/or derive a pipeline plan based on a future booking target.

Abstract: The shim-type implant for distraction and fusion of cervical facet joints is provided. The implant has a generally box-like shape with a blunt leading edge that may be centered or offset to the inferior face. The implant may include a graft window for enhanced osseous through-growth after implantation. The implant is coated with hydroxyapatite (HA) and/or tri-calcium phosphate (TCP) to allow for osteo-conduction, is porous, and has a roughened surface with serrations on the superior and inferior faces. The implant may be fabricated from a titanium or tantalum alloy. In an embodiment, a set of tools is provided with a chisel and one or tongs and one or more decorticators for inserting the implant.

Abstract: Presented herein are systems and methods for automated analysis of patient data. More particularly, in certain embodiments, the invention relates to systems and methods for predicting the context of a particular phrase (e.g. the name of a diagnosis/condition) in a clinical record of a patient using a reportability classifier. In another aspect, the invention relates to systems and methods for automatically identifying a potential care gap and/or adverse health trend for a patient from clinical data.

Abstract: Disclosed are T regulatory cells endogenously occurring or generated in vitro which possess regenerative activity. In one embodiment said T regulatory cells are created by culture with derivatives of activated/enhanced mesenchymal stem cells. Said derivatives include apoptotic bodies, conditioned media, exosomes, microvesicles, proteins and various metabolites. In one embodiment said mesenchymal stem cells are activated with cytokines such as interferon gamma. In other embodiments are said mesenchymal stem cells are activated by ligation of toll like receptors. Cells of the invention are useful for treatment of autoimmune, degenerative, and combination of autoimmune and degenerative disease. Other uses of said regenerative T cells include treatment of heart failure, liver failure, stroke, and ischemic diseases.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media relate to a handheld wireless endoscope image streaming apparatus. The apparatus may establish a wireless connection to a computer system. The apparatus may obtain, via a digital camera, video imagery via an endoscope, the video imagery including multiple frames. The apparatus may stream to a computer system video data.

Abstract: Provided herein are 2-amino-pyrazolyl-[1,2,4]triazolo [1,5a]pyridine derivatives. Such compounds are useful, for example, for the treatment and/or prevention of neurodegenerative diseases or disorders such as ophthalmological neurodegenerative disorders. This disclosure also features compositions containing the same as well as methods of using and making the same.

Abstract: The shim-type implant for distraction and fusion of cervical facet joints is provided. The implant has a generally box-like shape with a blunt leading edge that may be centered or offset to the inferior face. The implant may include a graft window for enhanced osseous through-growth after implantation. The implant is coated with hydroxyapatite (HA) and/or tri-calcium phosphate (TCP) to allow for osteo-conduction, is porous, and has a roughened surface with serrations on the superior and inferior faces. The implant may be fabricated from a titanium or tantalum alloy. In an embodiment, a set of tools is provided with a chisel and one or tongs and one or more decorticators for inserting the implant.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media relate to a handheld wireless endoscope image streaming apparatus. The apparatus may establish a wireless connection to a computer system. The apparatus may obtain, via a digital camera, video imagery via an endoscope, the video imagery including multiple frames. The apparatus may stream to a computer system video data.

Abstract: Disclosed are novel cellular populations generated by explosion of monocytic cells to conditioned media of regenerative cells. In one embodiment said regenerative cells are umbilical cord endothelial cells and said cells are pre-activated to possess enhance ability to reprogram said monocytic lineage cells. In one embodiment monocyte lineage cells are collected from leukopaks by plastic adherence and subsequently cultured in a manner to generate cells similar to M2 cells. In one embodiment said monocytic cells are cultured in a manner to generate myeloid derived suppressor cells. In one embodiment cells are generated to reducing inflammatory conditions. In another embodiment cells are generated for treatment of degenerative conditions. In another embodiment cells are generated for treatment of fibrosis.

Abstract: A particulate lyophilized platelet lysate composition suitable for use as a cell culture medium can include growth factors, cytokines, and chemokines released from lysis of source platelets, wherein cellular debris from the source platelets is removed (partially or fully) by filtration. The growth factors, cytokines, and chemokines are lyophilized to form a particulate lyophilized platelet lysate composition.

Abstract: A system and method for treating migraine and headache through a digital therapeutic. The systems and methods described herein allow a migraine patient to manage symptoms, triggers, and therapeutic lifestyle interventions through an interconnected system, facilitated by a care team, to treat the root causes of migraine, and improve patient quality of life. The method includes collecting datasets associated with migraine, headache, migraine-related comorbidities, and lifestyle behavior at the mobile device to analyze neurological trigger patterns. Using the digital therapeutic application allows a patient to monitor and track lifestyle habits, to receive real time interventions, otherwise missed in traditional care settings, helping the patient learn lifestyle interventions that may mitigate future attacks. Given the complex nature of treating migraine, therapeutic lifestyle interventions are tailored to a patient's Neuroindividuality and facilitated by a care team.

Abstract: Disclosed are means, methods and compositions of matter useful for prevention and/or reversion of type 1 diabetes by upregulation of myeloid suppressor cell activity in a mammal suffering from and/or at risk of developing type 1 diabetes. In one embodiment the invention teaches administration of immune cells that have been conditioned by exposure to regenerative cells, and/or cultured in the presence of factors produced from regenerative cells. In one embodiment said regenerative cells are umbilical cord derived mesenchymal stem cells. In one embodiment, immune cells that have been exposed to said regenerative cells are administered together with agents known to enhance myeloid suppressor cell activity. In another embodiment immune cells are administered together with exogenous myeloid suppressor cells.

Abstract: A system (100) includes an echocardiogram measurement tool (150) that determines a subset (152) of measurements from a list of echocardiogram measurements according to a view of an ultrasound imaging sequence (110) and a mapping (154) between the view and the subset of measurements.

Abstract: A system (100) includes an echocardiogram measurement tool (150) that determines a subset (152) of measurements from a list of echocardiogram measurements according to a view of an ultrasound imaging sequence (110) and a mapping (154) between the view and the subset of measurements.

Abstract: Various cells, stem cells, and stem cell components, including associated methods of generating and using such cells are provided. In one aspect, for example, an isolated cell that is capable of self-renewal and culture expansion and is obtained from a subepithelial layer of a mammalian umbilical cord tissue. Such an isolated cell expresses at least three cell markers selected from CD29, CD73, CD90, CD166, SSEA4, CD9, CD44, CD146, or CD105, and does not express at least three cell markers selected from CD45, CD34, CD14, CD79, CD106, CD86, CD80, CD19, CD117, Stro-1, or HLA-DR.

Abstract: Various cells, stem cells, and stem cell components, including associated methods of generating and using such cells are provided. In one aspect, for example, an isolated cell that is capable of self-renewal and culture expansion and is obtained from a subepithelial layer of a mammalian umbilical cord tissue. Such an isolated cell expresses at least three cell markers selected from CD29, CD73, CD90, CD166, SSEA4, CD9, CD44, CD146, or CD105, and does not express at least three cell markers selected from CD45, CD34, CD14, CD79, CD106, CD86, CD80, CD19, CD117, Stro-1, or HLA-DR.

Abstract: Various cells, stem cells, and stem cell components, including associated methods of generating and using such cells are provided. In one aspect, for example, an isolated cell that is capable of self-renewal and culture expansion and is obtained from a subepithelial layer of a mammalian umbilical cord tissue. Such an isolated cell expresses at least three cell markers selected from CD29, CD73, CD90, CD166, SSEA4, CD9, CD44, CD146, or CD105, and does not express at least three cell markers selected from CD45, CD34, CD14, CD79, CD106, CD86, CD80, CD19, CD117, Stro-1, or HLA-DR.

Abstract: Improved electrical and thermal properties of solder alloys are achieved by the use of micro-additives in solder alloys to engineer the electrical and thermal properties of the solder alloys and the properties of the reaction layers between the solder and the metal surfaces. The electrical and thermal conductivity of alloys and that of the reaction layers between the solder and the -metal surfaces can be controlled over a wide range of temperatures. The solder alloys produce stable microstructures wherein such stable microstructures of these alloys do not exhibit significant changes when exposed to changes in temperature, compared to traditional interconnect materials.